Age (mean) | 57 years (range 33 – 87 years) |
Sex | 83.5 % men, 16,5 % women |
Follow-up (mean) | 51.8 months (range 4 – 154 months) |
T stadium | 50 T1 tumours and 35 T2 tumours |
N stadium | 60 lymph node negative-and 25 lymph node positive carcinoma without extracapsular spread |
Grading | 17 well differentiated tumours (G1) 59 moderately differentiated tumours (G2) 9 weakly differentiated tumours (G3) |